Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Elisabet Guinó"'
Autor:
Mireia Obón-Santacana, Anna Díez-Villanueva, Maria Henar Alonso, Gemma Ibáñez-Sanz, Elisabet Guinó, Ana López, Lorena Rodríguez-Alonso, Alfredo Mata, Ana García-Rodríguez, Andrés García Palomo, Antonio J. Molina, Montse Garcia, Gemma Binefa, Vicente Martín, Victor Moreno
Publikováno v:
BMC Medicine, Vol 19, Iss 1, Pp 1-11 (2021)
Abstract Background Different risk-based colorectal cancer (CRC) screening strategies, such as the use of polygenic risk scores (PRS), have been evaluated to improve effectiveness of these programs. However, few studies have previously assessed its u
Externí odkaz:
https://doaj.org/article/733185c3c65f446a9006a4acf155d6ce
Autor:
Rebeca Sanz-Pamplona, Marilena Melas, Asaf Maoz, Stephanie L Schmit, Hedy Rennert, Flavio Lejbkowicz, Joel K Greenson, Xavier Sanjuan, Maria Lopez-Zambrano, M Henar Alonso, Chenxu Qu, Kevin J McDonnell, Gregory E Idos, Marissa Vignali, Ryan Emerson, Paul Fields, Elisabet Guinó, Cristina Santos, Ramon Salazar, Harlan S Robins, Gad Rennert, Stephen B Gruber, Victor Moreno
Publikováno v:
PLoS Medicine, Vol 17, Iss 9, p e1003292 (2020)
BackgroundIdentifying stage II patients with colorectal cancer (CRC) at higher risk of progression is a clinical priority in order to optimize the advantages of adjuvant chemotherapy while avoiding unnecessary toxicity. Recently, the intensity and th
Externí odkaz:
https://doaj.org/article/42eadb840c134c0fa73e57c1b9f33f7d
Autor:
Nuria Seguí, Elisabet Guinó, Marta Pineda, Matilde Navarro, Fernando Bellido, Conxi Lázaro, Ignacio Blanco, Victor Moreno, Gabriel Capellá, Laura Valle
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e86063 (2014)
Aberrant telomere length measured in blood has been associated with increased risk of several cancer types. In the field of hereditary non-polyposis colorectal cancer (CRC), and more particularly in Lynch syndrome, caused by germline mutations in the
Externí odkaz:
https://doaj.org/article/a8515c67e76b44bb83aa678677b58009
Autor:
Xavier Solé, Marta Crous-Bou, David Cordero, David Olivares, Elisabet Guinó, Rebeca Sanz-Pamplona, Francisco Rodriguez-Moranta, Xavier Sanjuan, Javier de Oca, Ramon Salazar, Victor Moreno
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e106748 (2014)
BackgroundAccurate detection of characteristic proteins secreted by colon cancer tumor cells in biological fluids could serve as a biomarker for the disease. The aim of the present study was to identify and validate new serum biomarkers and demonstra
Externí odkaz:
https://doaj.org/article/761aa31772e74ebbaf0fdc36a6585c81
Autor:
Nuria Seguí, Marta Pineda, Elisabet Guinó, Ester Borràs, Matilde Navarro, Fernando Bellido, Victor Moreno, Conxi Lázaro, Ignacio Blanco, Gabriel Capellá, Laura Valle
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e61286 (2013)
Telomere length variation has been associated with increased risk of several types of tumors, and telomere shortening, with genetic anticipation in a number of genetic diseases including hereditary cancer syndromes. No conclusive studies have been pe
Externí odkaz:
https://doaj.org/article/a0a18a6df08e4e15a259effde6bf383e
Autor:
Rebeca Sanz-Pamplona, Antoni Berenguer, David Cordero, Samantha Riccadonna, Xavier Solé, Marta Crous-Bou, Elisabet Guinó, Xavier Sanjuan, Sebastiano Biondo, Antonio Soriano, Giuseppe Jurman, Gabriel Capella, Cesare Furlanello, Victor Moreno
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e48877 (2012)
IntroductionThe traditional staging system is inadequate to identify those patients with stage II colorectal cancer (CRC) at high risk of recurrence or with stage III CRC at low risk. A number of gene expression signatures to predict CRC prognosis ha
Externí odkaz:
https://doaj.org/article/07e22085fbab488d96e4d6101fd40804
Autor:
Rosa Morros, Maria Angeles Quijada-Manuitt, Luisa C de la Peña-Negro, Elisabet Guinó, Gemma Ibáñez-Sanz, Victor Moreno
Publikováno v:
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
Background: A safe and effective colorectal cancer chemoprevention agent remains to be discovered. There is little evidence regarding the protective effect of chondroitin sulphate and glucosamine on colorectal cancer. We aimed to assess the associati
Autor:
Elisabet Guinó, Caridad Pontes, Mª Angeles Quijada-Manuitt, Gemma Ibáñez-Sanz, Victor Moreno, Rosa Morros, Luisa C de la Peña-Negro
Publikováno v:
EUROPEAN JOURNAL OF EPIDEMIOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
The use of bisphosphonates has been associated with a decrease in the risk of colorectal cancer (CRC) in observational studies, but with controversial results and difficult to interpret because of routine concomitant use of calcium and vitamin D. We
Autor:
Maria Henar Alonso, Elisabet Guinó, Victor Moreno, Mireia Obón-Santacana, Alfredo Mata, Montse Garcia, Gemma Binefa, Lorena Rodríguez-Alonso, Ana M. López, Ana García-Rodríguez, Vicente Martín, Gemma Ibáñez-Sanz, Antonio J. Molina, Andrés García Palomo, Anna Díez-Villanueva
Publikováno v:
BMC Medicine
BMC Medicine, Vol 19, Iss 1, Pp 1-11 (2021)
Dipòsit Digital de la UB
Universidad de Barcelona
BMC Medicine, Vol 19, Iss 1, Pp 1-11 (2021)
Dipòsit Digital de la UB
Universidad de Barcelona
Background Different risk-based colorectal cancer (CRC) screening strategies, such as the use of polygenic risk scores (PRS), have been evaluated to improve effectiveness of these programs. However, few studies have previously assessed its usefulness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::999741ab34aa79cce3408ad25ea966db
http://hdl.handle.net/2445/181317
http://hdl.handle.net/2445/181317
Autor:
Laia Paré-Brunet, Ferran Moratalla-Navarro, Victor Moreno, Miguel A. Peinado, María Berdasco, Ramon Salazar, M. Henar Alonso, Rebeca Sanz-Pamplona, David Cordero, Robert Carreras-Torres, Xavier Solé, Anna Díez-Villanueva, Elisabet Guinó, Susanna Aussó
Publikováno v:
Epigenomics
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Aim: Gain insight about the role of DNA methylation in the malignant growth of colon cancer. Patients & methods: Methylation and gene expression from 90 adjacent-tumor paired tissues and 48 healthy tissues were analyzed. Tumor genes whose change in e